Related references
Note: Only part of the references are listed.Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
Jose Luis Najera et al.
PLOS ONE (2010)
Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV/AIDS
Mariano Esteban
HUMAN VACCINES (2009)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans
Lichen Jing et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
The Interferon System and Vaccinia Virus Evasion Mechanisms
Beatriz Perdiguero et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
Petra Mooij et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity
Nadine van Montfoort et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer
Carmen E. Gomez et al.
CURRENT GENE THERAPY (2008)
Vaccinia virus-specific CD8+ T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans
Masanori Terajima et al.
HUMAN IMMUNOLOGY (2008)
A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus
Damien Chaussabel et al.
IMMUNITY (2008)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Alexandre Harari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?
Rafick-Pierre Sekaly
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Differential CD4(+) versus CD8(+) T-cell responses elicited by different poxvirus-based human immunodeficiency virus type I vaccine candidates provide comparable efficacies in primates
Petra Mooij et al.
JOURNAL OF VIROLOGY (2008)
EV01:: A phase I trial in healthy HIV negative volunteers to evaluate a clade CHIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
Pierre-Alexandre Bart et al.
VACCINE (2008)
EV02:: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
Sheena McCormack et al.
VACCINE (2008)
Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype
Alexandre Harari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
In vivo antigen stability affects DNA vaccine immunogenicity
Adriaan D. Bins et al.
JOURNAL OF IMMUNOLOGY (2007)
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC
Susana Guerra et al.
JOURNAL OF VIROLOGY (2007)
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B
Carmen Elena Gomez et al.
VACCINE (2007)
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
Carmen Elena Gomez et al.
VACCINE (2007)
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene
Jos Luis Najera et al.
JOURNAL OF VIROLOGY (2006)
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
Nancy A. Wilson et al.
JOURNAL OF VIROLOGY (2006)
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
N Frahm et al.
NATURE IMMUNOLOGY (2006)
Diversity in the acute CD8 T cell response to vaccinia virus in humans
LC Jing et al.
JOURNAL OF IMMUNOLOGY (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load
N Frahm et al.
JOURNAL OF VIROLOGY (2005)
Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus
SS Jackson et al.
JOURNAL OF VIROLOGY (2005)
Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses
DH O'Connor et al.
JOURNAL OF VIROLOGY (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SlVmac251-infected macaques
Z Hel et al.
VIROLOGY (2002)
Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy
E Tryniszewska et al.
JOURNAL OF IMMUNOLOGY (2002)
Containment of simian immunodeficiency virus infection in vaccinated macaques:: Correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses
Z Hel et al.
JOURNAL OF IMMUNOLOGY (2002)
Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes
XF Shen et al.
JOURNAL OF IMMUNOLOGY (2002)
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN
A Alcamí et al.
JOURNAL OF VIROLOGY (2000)
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
SA Migueles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
